[HIV-1 PR variants complexed with FDA drugs (P 61)]




Superposition of the current dimer and the dimer of 2NPH Superposition of chains D2 code sequences
P
D
B

I
D
(Front view)


Cur.: yellow
2NPH: blue
(Top view)


Cur.: yellow
2NPH: blue
(Front view)

Chain A: black
Chain B: white
  • Z-score and RMSD of the dimer superposition with 2NPH (CACB or CBCA1))
  • Ligand name (value of the inhibitor constant Ki)
  • Mutations from the Consensus B amino acid sequence2) (Red are resistance mutations)
  • Difference with 2NPH (chain L)
  • Difference with 2NPH (chain R)
  • D2 code of chain L (left in the front view)
  • D2 code of chain R (right in the front view)

1) The CACB and CBCA flag
: CACB indicates that chain L and chain R correspond to chain A and chain B of the PDB file, respectively.
                                                    CBCA indicates that chain L and chain R correspond to chain B and chain A of the PDB file, respectively.

                                              1         2         3         4         5         6         7         8         9
                                     123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890123456789
2) Consensus B amino acid sequence : PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF



The base D2 code sequences for the dimer comparisons (2NPH: wild type HIV-1 PR complexed with the substrate RT-RH)

2
N
P
H
jpg image jpg image
jpg image Z-Score -  RMSD 0.0A (identical)  (CACB)
Ligand substrate RT-RH (colored black in the left figures)
               1         2         3         4         5         6         7         8         9
     123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890123456789
Muta
   V                                 S                                                         M   
DifL
DifR
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR00000000000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--



Crystal structures : unliganded (2) / substrates (2) / FDA drugs (18)

1
G
6
L
jpg image jpg image
jpg image
Z-Score 35.0  RMSD 0.4A  (CACB, TETHERED DIMER)
Ligand  None
Mu(L)  V                                 S                                                         M   
Mu(R)  V                                 S                                                           
DifL                              +                                                                    
DifR                              +                                                                    
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR0000R
Ch R 30001R00R000000RRG00000R0QBGRG0000000000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--
1
L
V
1
jpg image jpg image
jpg image
Z-Score 35.4  RMSD 0.4A  (CACB, TETHERED DIMER)
Ligand  
None
Mu(L)  V                                 S                                                         M   
Mu(R)  V                                 S                                                         A 
DifL                              +                                                         +
DifR       +                      +                                     +                   ++
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RRG000000000R0R00000QBAAAABR0000O
Ch R 30001RG0R000000RRG00000R0QBGRG0000000000000000000QB000000000R00000R0G000000000R0R00000QB1AAABR000--
3
D
O
X
jpg image jpg image
jpg image
Z-Score 36.0  RMSD 0.4A  (CACB, TETHERED DIMER)
Ligand 
substrate MC-CA
Mu(L)  V                                 S                                                         M   
Mu(R)  V                                 S                                                         A 
DifL                                                                     +                  ++
DifR       +
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RR0000000000R0R00000QB1AAABR0000O
Ch R 30001RG0R000000RRG00000R0QBGR00000000000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--
3
D
3
T
jpg image jpg image
jpg image Z-Score 34.2  RMSD 0.6A  (CACB)
Ligand substrate P1-P6
Muta                    R    N         DI    K                           K                   M   L
DifL       +                          +++
DifR     +                            +++
Ch L --001RG0R000000RRG00000R0QBGR00001RG00000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --00RR00R000000RRG00000R0QBGR00001RG0000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--
1
H
X
B
jpg image jpg image
jpg image Z-Score 35.0  RMSD 0.4A  (CBCA)
Ligand saquinavir (approved in 1995, the first PI)
Muta   V                                 S
DifL                              +                                                +     +   +
DifR                                                  +                                     ++
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RRG00000000000R00030QA9AAABR000--
Ch R --001R00R000000RRG00000R0QBGR000000000000000000000B000000000R00000RRG000000000R0R00000QB9AAABR000--
1
S
G
U
jpg image jpg image
jpg image Z-Score 34.6  RMSD 0.5A  (CACB)
Ligand indinavir (1996)
Muta                    R           IF  IS                V        P       V          A V     M
DifL                                                                     +         +
DifR                                                   +                 +         +        ++
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RR000000000000R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR00000000000000000000Q3000000000R00000RR000000000000R00000QB1AAABR000--
2
B
7
Z
jpg image jpg image
jpg image Z-Score 34.7  RMSD 0.5A  (CACB)
Ligand 
indinavir (1996)
Muta                    R           IF  IS        I                P       V          A V     M
DifL                                  +                                                     +
DifR                                  +               ++                                    ++
Ch L --001R00R000000RRG00000R0QBGR0000R0000000000000000R000000000R00000RRG000000000R0R00000QBAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR0000R0000000000000000R000000000R00000RRG000000000R0R00000QB1AAABR000--
1
R
L
8
jpg image jpg image
jpg image Z-Score 35.8  RMSD 0.4A  (CACB)
Ligand ritonavir (1996)
Muta                                     S                                            A
DifL       +                                                            +                   ++
DifR                                                                    +
Ch L --001RG0R000000RRG00000R0QBGR000000000000000000000R000000000R00000R0G000000000R0R00000QB1AAABR000--
Ch R --001R00R000000RRG00000R0QBGR00000000000000000000QB000000000R00000R0G000000000R0R00000QAAAAABR000--
1
S
H
9
jpg image jpg image
jpg image Z-Score 33.9  RMSD 0.5A  (CACB)
Ligand ritonavir (1996)
Muta                    R           IF  IS                V        P       V          A V     M
DifL       +                      +             +                                  +
DifR       +                                                                       +        +
Ch L --001RG0R000000RRG00000R0QBGRG00000000000003000000R000000000R00000RRG00000000000R00000QAAAAABR000--
Ch R --001RG0R000000RRG00000R0QBGR00000000000000000000QB000000000R00000RRG00000000000R00000QBAAAABR000--
2
B
6
0
jpg image jpg image
jpg image Z-Score 34.7  RMSD 0.5A  (CBCA)
Ligand ritonavir (1996)
Muta                    R           IF  IS                         P       V          A       M
DifL                              +                                      +
DifR                                                                     +            +     ++
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RR0000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR00000000000000000000QB000000000R00000RR0000000000R0RG0000QB1AAABR000--
2
P
Y
M
jpg image jpg image
jpg image Z-Score 35.1  RMSD 0.5A  (CACB)
Ligand nelfinavir (1997)
Muta                              N      S                                                  D
DifL                              +                                      +
DifR                                                  ++
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RR0000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
2
P
Y
N
jpg image jpg image
jpg image Z-Score 35.3  RMSD 0.4A  (CBCA)
Ligand nelfinavir (1997)
Muta                              N      S                                 V
DifL                                                                               +
DifR                                                  ++                           +
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG00000000030R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG00000000030R00000QAAAAABR000--
2
Q
6
3
jpg image jpg image
jpg image Z-Score 35.2  RMSD 0.5A  (CACB)
Ligand nelfinavir (1997)
Muta                              N      S                 A                                  M
DifL                              +
DifR                              +                   ++
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
2
Q
6
4
jpg image jpg image
jpg image Z-Score 35.6  RMSD 0.4A  (CBCA)
Ligand nelfinavir (1997)
Muta                              N      S
DifL                              +
DifR                              +                   ++
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGRG0000000000000000000RG000000000R00000RRG000000000R0R00000QAAAAABR000--
2
Q
A
K
jpg image jpg image
jpg image Z-Score 35.2  RMSD 0.5A  (CACB)
Ligand nelfinavir (1997)
Muta                              N      S                 A                                  M
DifL                                                                     +
DifR                              +                                                +
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RR0000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGRG0000000000000000000QB000000000R00000RRG00000000000R00000QAAAAABR000--
1
H
P
V
jpg image jpg image
jpg image Z-Score 35.0  RMSD 0.4A  (CBCA)
Ligand amprenavir (1999)  Ki=0.6nM
Muta                                     S
DifL     +
DifR                        +                                          +
Ch L --00PR00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG0000000QBGR00000000000000000000QB000000000R000000RG000000000R0R00000QAAAAABR000--
2
R
K
G
jpg image jpg image
jpg image Z-Score 34.1  RMSD 0.5A  (CACB, length 100)
Ligand lopinavir (2000)
Muta          F  V  A   M           I  EE S     T  VV      M         V      V          A
DifL                                   +++                                +
DifR                                   +++             +                  +
Ch L --001R00R000000RRG00000R0QBGR00000QBG00000000000000R000000000R00000RR0000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR00000QBG00000000000000B000000000R00000RR0000000000R0R00000QAAAAABR000--
2
R
K
F
jpg image jpg image
jpg image Z-Score 34.9  RMSD 0.5A  (CBCA)
Ligand lopinavir (2000)  Ki=0.83nM  (0.018nM for WT)
Muta          F  V  A   M           I    S     T  VV      M         V      V          A
DifL         +
DifR       + +                                                           +
Ch L --001R003000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001RG03000000RRG00000R0QBGR00000000000000000000QB000000000R00000RR0000000000R0R00000QAAAAABR000--
2
Z
5
4
jpg image jpg image
jpg image Z-Score 35.7  RMSD 0.4A  (CACB)
Ligand lopinavir (2000)  Ki=100-fold against the wild type
Muta                                     S         A      V
DifL                                                                     +
DifR                                                                     +
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RR0000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGR00000000000000000000QB000000000R00000RR0000000000R0R00000QAAAAABR000--
1
M
U
I
jpg image jpg image
jpg image Z-Score 34.5  RMSD 0.4A  (CACB)
Ligand lopinavir (2000)
Muta                                     S
DifL                                        +         ++             +                      ++
DifR                        +
Ch L --001R00R000000RRG00000R0QBGR0000000000G000000000QB000000000R00030RRG000000000R0R00000QB1AAABR000--
Ch R --001R00R000000RRG0000030QBGR00000000000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--
2
Q
H
C
jpg image jpg image
jpg image Z-Score 35.5  RMSD 0.4A  (CACB)
Ligand lopinavir (2000)
Muta                                     S         A
DifL
DifR       +
Ch L --001R00R000000RRG00000R0QBGR000000000000000000000R000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001RG0R000000RRG00000R0QBGR00000000000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--
2
A
Q
U
jpg image jpg image
jpg image Z-Score 35.7  RMSD 0.4A  (CACB)
Ligand atazanavir (2003)  Ki=0.48nM
Muta                                     S
DifL                              +                    +
DifR                              +
Ch L --001R00R000000RRG00000R0QBGRG00000000000000000000B000000000R00000RRG000000000R0R00000QAAAAABR000--
Ch R --001R00R000000RRG00000R0QBGRG0000000000000000000QB000000000R00000RRG000000000R0R00000QAAAAABR000--



[The D2 codes]

[The DSSP code]